The following is a summary of “Microcystoid macular edema in epiretinal membrane: not a retrograde maculopathy,” published in ...

Dogs can develop edema around the body. The condition can range from mild to severe and even life-threatening, depending on ...

Learn how to reduce puffiness with these proven natural remedies, focusing on hydration, sodium reduction, sleep quality, and more for lasting relief.

BofA lowered the firm’s price target on 4D Molecular (FDMT) to $42 from $46 on Friday and kept a Buy rating on the shares. The firm notes 4D ...

Phase 1b clinical data underpins sozinibercept's potential as a novel, first-in-class VEGF-C/D 'trap' to improve visual and anatomic outcomes in DME< ...

An announcement from Opthea Limited ( (AU:OPT) ) is now available.

D Molecular Therapeutics reaches agreement with FDA for phase 3 trial design of DME candidate 4D-150, showing promising ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...

ABBVRGX-314 is under clinical development by AbbVie and currently in Phase II for Diabetic Macular Edema. According to GlobalData, Phase II drugs for Diabetic Macular Edema have a 47% phase transition ...

Drug-induced lung disease cases in France mostly involved ILD, pulmonary edema, and pulmonary fibrosis, largely linked to cancer and CV drugs.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...